Component
Protein kinase A
Independent biological entity. Read linked claims for experimental scope and context.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
The PKA signaling pathway participated in DIM-mediated ERalpha activation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/dim-research/25048790.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3729748e0cd55782230ad119eddfb3a79e0cdfd78503f5dbf397ae0ab5f68a17", "start_char": 0, "end_char": 1824, "text_sha256": "3729748e0cd55782230ad119eddfb3a79e0cdfd78503f5dbf397ae0ab5f68a17"}
- experimental_model
- Gene expression, chromatin, inhibitors and growth assays
- exposure
- DIM 10 versus 50 micromolar; estradiol absent
- limitations
- The authors call 10 micromolar obtainable, but this is not a demonstrated human tissue concentration or clinical tumor outcome. Estrogen context and concentration matter.
- nutrient_topic
- Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. · 3,3'-Diindolylmethane / DIM
- organism
- Human MCF-7 and T47D cells
- plain_language
- A kinase pathway connected exposure to receptor signaling.
- primary_references
- [dim-p25048790] Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol. (2014). https://pubmed.ncbi.nlm.nih.gov/25048790/ DOI: 10.1186/1471-2407-14-524
- tissue_or_cell_type
- ERalpha and proliferation
Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17) · lines 623–634
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Gene expression, chromatin, inhibitors and growth assays · source_derived_draft · unverified_draft
### dim-pka-eralpha The PKA signaling pathway participated in DIM-mediated ERalpha activation. Condition category: normal nutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. plain_language: A kinase pathway connected exposure to receptor signaling. organism: Human MCF-7 and T47D cells tissue_or_cell_type: ERalpha and proliferation experimental_model: Gene expression, chromatin, inhibitors and growth assays limitations: The authors call 10 micromolar obtainable, but this is not a demonstrated human tissue concentration or clinical tumor outcome. Estrogen context and concentration matter. exposure: DIM 10 versus 50 micromolar; estradiol absent evidence_span: {"source_cache": "artifacts/dim-research/25048790.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3729748e0cd55782230ad119eddfb3a79e0cdfd78503f5dbf397ae0ab5f68a17", "start_char": 0, "end_char": 1824, "text_sha256": "3729748e0cd55782230ad119eddfb3a79e0cdfd78503f5dbf397ae0ab5f68a17"} [dim-p25048790] Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol. (2014). https://pubmed.ncbi.nlm.nih.gov/25048790/ DOI: 10.1186/1471-2407-14-524
Complete structured claim and evidencePKA phosphorylated CFTR regulatory-domain serines; combined mutation of the four tested sites abolished the cAMP-responsive chloride signal.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chloride-research/1716180.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8b48fbd8f484e2ed58382af512ac2b1f08ca87b9ea2db5faf920ce71d1f631d5", "start_char": 0, "end_char": 961, "text_sha256": "8b48fbd8f484e2ed58382af512ac2b1f08ca87b9ea2db5faf920ce71d1f631d5"}
- experimental_model
- PKA phosphorylation and CFTR mutagenesis
- exposure
- Serines 660, 737, 795 and 813
- limitations
- Early site mapping; do not imply these are the only regulatory sites or endorse the historical gating model.
- nutrient_topic
- Chloride research collection; topical membership is not evidence of a direct dietary effect. · Chloride
- organism
- Human CFTR in cells
- plain_language
- A kinase switches the channel into a state that can respond to stimulation.
- primary_references
- [chloride-p1716180] Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. (1991). https://pubmed.ncbi.nlm.nih.gov/1716180/ DOI: 10.1016/0092-8674(91)90446-6
- tissue_or_cell_type
- CFTR regulatory domain
Chloride: transport, acid-base balance, nutrient interactions and loss states (2026-09-17) · lines 237–248
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · PKA phosphorylation and CFTR mutagenesis · source_derived_draft · unverified_draft
### chloride-pka-cftr PKA phosphorylated CFTR regulatory-domain serines; combined mutation of the four tested sites abolished the cAMP-responsive chloride signal. Condition category: normal nutrient_topic: Chloride research collection; topical membership is not evidence of a direct dietary effect. plain_language: A kinase switches the channel into a state that can respond to stimulation. organism: Human CFTR in cells tissue_or_cell_type: CFTR regulatory domain experimental_model: PKA phosphorylation and CFTR mutagenesis limitations: Early site mapping; do not imply these are the only regulatory sites or endorse the historical gating model. exposure: Serines 660, 737, 795 and 813 evidence_span: {"source_cache": "artifacts/chloride-research/1716180.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8b48fbd8f484e2ed58382af512ac2b1f08ca87b9ea2db5faf920ce71d1f631d5", "start_char": 0, "end_char": 961, "text_sha256": "8b48fbd8f484e2ed58382af512ac2b1f08ca87b9ea2db5faf920ce71d1f631d5"} [chloride-p1716180] Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. (1991). https://pubmed.ncbi.nlm.nih.gov/1716180/ DOI: 10.1016/0092-8674(91)90446-6
Complete structured claim and evidence
Where it participates (unsigned role)
PTH increases TRPV5 activity through cAMP-PKA-dependent phosphorylation at T709 in receptor/channel expression assays.
Experimental context and source evidence
- experimental_model
- HEK293 expression, calcium uptake, FRET, patch clamp and TRPV5 mutagenesis
- limitations
- Response required strong intracellular calcium buffering; cultured-cell mechanism.
- nutrient_topic
- Calcium research collection; topical membership is not evidence of a direct dietary effect. · Calcium
- organism
- Heterologous HEK293 expression system
- plain_language
- PTH can increase calcium entry through TRPV5.
- primary_references
- [degroot2009] Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation (2009). https://pmc.ncbi.nlm.nih.gov/articles/PMC2723979/ DOI: 10.1681/ASN.2008080873
- tissue_or_cell_type
- Plasma membrane; distal-nephron mechanism
Calcium: mechanism-first literature curation (2026-09-17) · lines 58–67
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · HEK293 expression, calcium uptake, FRET, patch clamp and TRPV5 mutagenesis · source_derived_draft · unverified_draft
### pth-activates-trpv5 PTH increases TRPV5 activity through cAMP-PKA-dependent phosphorylation at T709 in receptor/channel expression assays. Condition category: normal nutrient_topic: Calcium research collection; topical membership is not evidence of a direct dietary effect. plain_language: PTH can increase calcium entry through TRPV5. organism: Heterologous HEK293 expression system tissue_or_cell_type: Plasma membrane; distal-nephron mechanism experimental_model: HEK293 expression, calcium uptake, FRET, patch clamp and TRPV5 mutagenesis limitations: Response required strong intracellular calcium buffering; cultured-cell mechanism. [degroot2009] Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation (2009). https://pmc.ncbi.nlm.nih.gov/articles/PMC2723979/ DOI: 10.1681/ASN.2008080873
Complete structured claim and evidence6-Gingerol enhanced measured PKA activity in the stimulated human-neutrophil experiments.
Experimental context and source evidence
- dose
- 6-Gingerol 10 micromolar with forskolin or cAMP stimulation
- duration
- Kinase assay incubation 90 min; cellular pretreatment interval not resolved here
- evidence_access
- Primary open full text, results, figure legends and methods, plus PubMed metadata.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Neutrophils isolated from healthy human donors
- limitations
- Activity response, not demonstrated direct binding of gingerol to PKA.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Neutrophils isolated from healthy human donors
- plain_language
- 6-Gingerol enhanced measured PKA activity in the stimulated human-neutrophil experiments.
- primary_references
- Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385
- route
- Ex vivo exposure and lysate kinase assay
- tissue
- Human neutrophil PKA activity assay
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 470–479
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Neutrophils isolated from healthy human donors · source_derived_draft · unverified_draft
## gingerols-6-neutrophil-pka 6-Gingerol enhanced measured PKA activity in the stimulated human-neutrophil experiments. Model/species: Neutrophils isolated from healthy human donors Tissue: Human neutrophil PKA activity assay Exposure: 6-Gingerol 10 micromolar with forskolin or cAMP stimulation Route: Ex vivo exposure and lysate kinase assay Duration: Kinase assay incubation 90 min; cellular pretreatment interval not resolved here Limits: Activity response, not demonstrated direct binding of gingerol to PKA. Primary reference: Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385 Access: Primary open full text, results, figure legends and methods, plus PubMed metadata.
Complete structured claim and evidenceAdding a PKA inhibitor weakened 6-gingerol suppression of APS-IgG-triggered NETosis in human neutrophils.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- dose
- 6-Gingerol with APS IgG and PKA inhibitor; exact inhibitor dose not specified in inspected text
- duration
- 3 h NETosis assay
- evidence_access
- Primary open full text, results, figure legends and methods, plus PubMed metadata.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Human donor neutrophils with pharmacologically inhibited PKA
- limitations
- Supports a PKA-sensitive component; pharmacological inhibition is not selective genetic deletion or a nutrient deficiency.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Human donor neutrophils with pharmacologically inhibited PKA
- plain_language
- Adding a PKA inhibitor weakened 6-gingerol suppression of APS-IgG-triggered NETosis in human neutrophils.
- primary_references
- Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385
- route
- Ex vivo co-exposure
- tissue
- Human neutrophils
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 481–490
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human donor neutrophils with pharmacologically inhibited PKA · source_derived_draft · unverified_draft
## gingerols-pka-blockade Adding a PKA inhibitor weakened 6-gingerol suppression of APS-IgG-triggered NETosis in human neutrophils. Model/species: Human donor neutrophils with pharmacologically inhibited PKA Tissue: Human neutrophils Exposure: 6-Gingerol with APS IgG and PKA inhibitor; exact inhibitor dose not specified in inspected text Route: Ex vivo co-exposure Duration: 3 h NETosis assay Limits: Supports a PKA-sensitive component; pharmacological inhibition is not selective genetic deletion or a nutrient deficiency. Primary reference: Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385 Access: Primary open full text, results, figure legends and methods, plus PubMed metadata.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.